• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Vor Biopharma Inc. - Common Stock (NQ:VOR)

    1.980 +0.020 (+1.02%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 8, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 4,197,572
    Open 1.960
    Bid (Size) 1.930 (16)
    Ask (Size) 1.970 (9)
    Prev. Close 1.960
    Today's Range 1.910 - 2.010
    52wk Range 0.1311 - 3.290
    Shares Outstanding 66,956,800
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Vor Bio Appoints Adi Osovsky, S.J.D. as General Counsel
    Experienced legal leader brings deep expertise in governance, strategic transactions, and risk management to support Vor Bio’s growth 
    From Vor Biopharma
    Via GlobeNewswire
    FDA Eases Monitoring Burden For Kidney Disease Patients On Travere Therapeutics' Filspari
    FDA eases REMS labeling for Travere's Filspari, reducing liver monitoring and removing embryo-fetal toxicity rules, with FSGS approval review ongoing. 
    Via Benzinga

    Performance

    YTD
    +76.8%
    +76.8%
    1 Month
    -4.3%
    -4.3%
    3 Month
    +788.3%
    +788.3%
    6 Month
    +120.0%
    +120.0%
    1 Year
    +81.7%
    +81.7%

    More News

    Read More
    Vor Bio's Investigational Drug Scores Phase 3 Win In Autoimmune Kidney Disease Trial
    Via Benzinga
    Telitacicept Achieved Primary Endpoint in Phase 3 Clinical Study for IgA Nephropathy
    From Vor Biopharma
    Via GlobeNewswire
    Vor Bio Stock Jumped 19% Today And Retail Investors Are Eyeing A Breakout Rally: Here’s What’s Happening
    Via Stocktwits
    Vor Bio to Participate in Upcoming Investor Conferences
    From Vor Biopharma
    Via GlobeNewswire
    Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Vor Biopharma
    Via GlobeNewswire
    Vor Bio Rallies On Strong Data For Autoimmune Drug Candidate
    Via Benzinga
    Telitacicept Achieved Primary Endpoint in Phase 3 Clinical Study for Primary Sjögren's Disease with Telitacicept, a Dual BAFF/APRIL Inhibitor
    From Vor Biopharma
    Via GlobeNewswire
    Vor Bio Appoints Seasoned Biotech Executive Dallan Murray as Chief Commercial Officer
    From Vor Biopharma
    Via GlobeNewswire
    Vor Bio Appoints Biotech Industry Leaders Alexander (Bo) Cumbo and Michel Detheux, Ph.D. to Board of Directors
    From Vor Biopharma
    Via GlobeNewswire
    Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From Vor Biopharma
    Via GlobeNewswire
    Vor Bio Appoints Qing Zuraw, M.D. as Chief Development Officer
    From Vor Biopharma
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Vor Bio Appoints Veteran Biotech Executive Sandy Mahatme as Chief Financial Officer and Chief Business Officer
    From Vor Biopharma
    Via GlobeNewswire
    Why ENDRA Life Sciences Shares Are Trading Higher By Over 61%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Top stock movements in today's session.
    Via Chartmill
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Here are the top movers in Monday's session.
    Via Chartmill
    Top stock movements in today's session.
    Via Chartmill
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Vor Bio Report Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From Vor Biopharma
    Via GlobeNewswire
    These stocks have an unusual volume in today's session
    Via Chartmill
    Let's take a look at the stocks that are in motion in today's session.
    Via Chartmill
    Vor Biopharma's RemeGen Deal Paves Way For Multi-Billion Dollar Autoimmune Market
    Via Benzinga

    Frequently Asked Questions

    Is Vor Biopharma Inc. - Common Stock publicly traded?
    Yes, Vor Biopharma Inc. - Common Stock is publicly traded.
    What exchange does Vor Biopharma Inc. - Common Stock trade on?
    Vor Biopharma Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Vor Biopharma Inc. - Common Stock?
    The ticker symbol for Vor Biopharma Inc. - Common Stock is VOR on the Nasdaq Stock Market
    What is the current price of Vor Biopharma Inc. - Common Stock?
    The current price of Vor Biopharma Inc. - Common Stock is 1.980
    When was Vor Biopharma Inc. - Common Stock last traded?
    The last trade of Vor Biopharma Inc. - Common Stock was at 09/08/25 04:00 PM ET
    What is the market capitalization of Vor Biopharma Inc. - Common Stock?
    The market capitalization of Vor Biopharma Inc. - Common Stock is 132.57M
    How many shares of Vor Biopharma Inc. - Common Stock are outstanding?
    Vor Biopharma Inc. - Common Stock has 133M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.